Medical Director
Distinguished Clinical Professor of Medicine
University of Colorado Health Sciences Center
Colorado Center for Bone Research
Paul Miller is Medical Director at the Colorado Center for Bone Research at Panorama Orthopedics and Spine Center in Golden, CO. He is also a Distinguished Clinical Professor of Medicine at the University of Colorado, Health Sciences Center. He is Board Certified in both Internal Medicine and Nephrology. He is an internationally recognized physician specializing in metabolic bone disease and is widely considered a leading authority on bone biology, prevention, and treatment of metabolic bone disorders, including osteoporosis.
Dr. Miller’s research focuses on the treatment of osteoporosis in postmenopausal women, and he is the Principal Investigator in a number of clinical trials evaluating the safety and efficacy of current and potential therapies. He is author and co-author of over 300 peer-reviewed publications, and 50 textbook chapters, atlases, and books.
Dr. Miller is the founding President of The International Society for Clinical Densitometry and Emeritus Editor-in-Chief of the Journal of Clinical Densitometry. He serves on the editorial boards of Osteoporosis International, Calcified Tissues International, Journal of Women’s Heath, and the National Osteoporosis Foundation’s Osteoporosis: Clinical Updates Newsletter, and Up-to-Date. He is a reviewer for the Annals of Internal Medicine, Calcified Tissue International, Journal of Bone and Mineral Research, The New England Journal of Medicine and JAMA.
Dr. Miller received an Honorary Doctor of Science from his undergraduate alma mater, Gettysburg College, and his medical degree from The George Washington University School of Medicine in Washington, DC, which also awarded him in 2103 The Distinguished Alumni Award. He served his internship, residency, and chief residency at the University of Rochester School of Medicine, Strong Memorial Hospital, Rochester, NY, and completed clinical and research fellowships in renal diseases at the University of Colorado Medical Center in Denver. He has remained in Denver since 1974, involved in renal medicine and metabolic bone disease from 1977 to 1994, and then established the Colorado Center for Bone Research—a clinical and research facility caring for a broad spectrum of metabolic bone diseases. Dr., Miller is Principal Investigator or Co-Investigator in FDA-approved therapies for osteoporosis, Paget’s disease, renal bone disease, osteogenesis imperfecta, steroid-induced osteoporosis, hypophosphatasia, and other rare bone diseases. He is board certified in both internal medicine and nephrology.
Dr. Miller disclosed the following conflicts of interest for this workshop:
- Research grants: Alexion, Amgen, Lilly, Merck, Radius Health, Regeneron (all paid to Panorama general research fund)
- Scientific advisory boards: Amgen, Radius Health, Sandoz, NBHA